Wegovy 0.25mg Injection contains semaglutide, a GLP-1 receptor agonist prescribed for chronic weight management in eligible adults and adolescents with obesity. As the starting dose in the Wegovy treatment plan, it helps regulate appetite, increase feelings of fullness, and support healthy weight-loss goals when combined with a reduced-calorie diet and regular physical activity. The convenient once-weekly injection is designed to help patients begin their weight management journey under medical supervision.

Wegovy 1mg Injection contains semaglutide, a GLP-1 receptor agonist prescribed for chronic weight management in eligible adults and adolescents with obesity. As part of the recommended dose-escalation schedule, Wegovy 1mg helps reduce appetite, increase feelings of fullness, and support healthy weight loss when combined with a reduced-calorie diet and regular physical activity. The convenient once-weekly injection helps patients stay on track with their long-term weight management goals under medical supervision.